Welcome to our dedicated page for Transdigm Group SEC filings (Ticker: TDG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TransDigm Group Incorporated (NYSE: TDG) files a variety of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its aerospace components business, capital structure and governance. This page compiles TransDigm’s SEC filings and pairs them with AI-powered summaries to help readers interpret the information more efficiently.
Investors can use this resource to locate annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically describe TransDigm’s business segments, risk factors, product categories and financial results. For this company, filings often discuss its role as a designer, producer and supplier of highly engineered aircraft components, its organization into segments such as power and control and airframes, and its use of acquisitions and financial leverage as part of its strategy, as reflected in the Polygon description and company disclosures.
Current reports on Form 8-K are particularly important for tracking material events at TransDigm. Recent 8-K filings describe acquisitions such as the Simmonds Precision Products business and a definitive agreement to acquire Stellant Systems, debt offerings and amendments to the company’s credit agreement, special cash dividends funded with new debt and changes in executive leadership and board composition. These documents provide timely details on transactions, financing terms and governance decisions.
This page also offers access to filings related to debt instruments and credit agreements, where TransDigm outlines terms for senior secured notes, senior subordinated notes and term loans, as well as any amendments that reprice or extend these facilities. Where available, insider transaction reports on Form 4 and proxy statements on Schedule 14A can shed light on executive and director share ownership and compensation structures.
Stock Titan’s platform enhances these filings with AI-generated highlights and explanations, helping users quickly identify key sections, understand complex capital structure language and see how new 8-K events connect to prior disclosures. Real-time updates from EDGAR ensure that new TransDigm filings appear promptly, while the AI layer reduces the time needed to parse lengthy documents and track the regulatory record for TDG.
TransDigm Group (TDG)8,700 stock options on 11/04/2025 with an exercise price of $1,291.97 per share.
The options vest 50% in 2029 and 50% in 2030, subject to the achievement of annual operating performance targets, and expire on 11/04/2035. The filing lists direct ownership.
TransDigm Group (TDG) reported a Form 4 for Co‑Chief Operating Officer Joel Reiss, reflecting a grant of stock options for 9,700 shares at an exercise price of $1,291.97 on 11/04/2025.
The options expire on 11/04/2035 and are scheduled to vest 50% in 2029 and 50% in 2030, subject to achieving annual operating performance targets in each year. Following the grant, 9,700 derivative securities are beneficially owned on a direct basis.
TransDigm Group (TDG) disclosed a Form 4 showing its President & CEO, Michael Lisman, received stock option grants on 11/04/2025. Two awards were reported with an exercise price of $1,291.97 and an expiration of 11/04/2035 (Transaction Code: A). The first grant covers 75,696 options; the second covers 3,907 options. Both were acquired at $0 for the derivative security and are listed as Direct (D) ownership.
Vesting is performance-based: the 75,696 options vest 20% per year over five years beginning September 30, 2026, subject to annual operating performance targets. The 3,907 options vest 80% in 2026 and 20% in 2027, subject to similar targets.
TransDigm Group (TDG) director filed an initial ownership report (Form 3) for an event on 10/23/2025.
The filing lists 4,000 shares of common stock (direct) and multiple stock options. Notable grants include 22,100 options at $559.78 (exercisable 09/30/2023, expiring 11/15/2029) and 17,160 options at $643 (exercisable 09/30/2025, expiring 11/12/2031). Additional options include 2,600 at $582.8 and 4,730 at $869.73.
Some options are held indirectly by a Family Trust (3,000 and 2,375 options at $476.81, expiring 04/25/2029). The report notes it was filed late by 2 days due to administrative delays.
TransDigm Group (TDG) reported an insider transaction by its Co‑Chief Operating Officer. On 11/03/2025, the officer exercised 290 stock options at $269.42 and on the same day sold 290 common shares at a weighted average price of $1,310 (within a range of $1,310.0000–$1,310.9999).
Following these transactions, the officer directly owns 1,055 common shares and holds 2,030 stock options outstanding.
TDG filed a Form 144 indicating a proposed sale of 290 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $379,467.90. The approximate sale date is 11/03/2025 on the NYSE.
The securities to be sold were acquired on 11/03/2025 via the exercise of stock options, paid in cash. Over the past three months, the filing lists a Rule 10b5-1 transaction for Patrick J. Murphy on 10/27/2025 totaling 580 shares for gross proceeds of $785,760.80. Shares outstanding are stated as 56,350,285.
TransDigm Group (TDG): insider transaction reported. On 10/27/2025, the Fortuna Trust dated June 1, 2018, affiliated with a company director, exercised 700 stock options at $105.88 and sold 700 common shares at an average $1,360. Following these transactions, the trust held 8,158 common shares indirectly. The option exercise related to a grant exercisable since 09/30/2018 and expiring 04/25/2028, with 72,800 derivative securities remaining indirectly held.
TransDigm Group (TDG): Co-Chief Operating Officer reported an option exercise and same-day sale on 10/27/2025. The filing shows an M-code exercise of 580 shares via stock options at $269.42 per share, followed by an S-code sale of 580 shares at a weighted average price of $1,354.76.
After these transactions, the reporting person directly owned 1,055 shares of common stock. The sale price reflects trades within the disclosed range of $1,354.7600–$1,355.7599. Derivative holdings listed following the transaction show 2,320 stock options remaining outstanding, with the exercised grant originally dated 09/30/2020 and expiring 11/10/2026.
TransDigm Group (TDG) reported a Form 144 notice for a proposed sale of 580 common shares with an aggregate market value of $788,394.00. The contemplated sales are listed for execution through Morgan Stanley Smith Barney LLC on the NYSE with an approximate sale date of 10/27/2025.
The shares were acquired on 10/27/2025 via an exercise of stock options for 580 shares, paid in cash. In the past three months, the filer also reported 290 shares sold on 08/01/2025 for $461,906.20 under a 10b5-1 plan.
TransDigm (TDG): A shareholder filed a Form 144 notice to sell up to 700 shares of common stock through Morgan Stanley Smith Barney LLC. The filing lists an aggregate market value of 951,510 and identifies the NYSE as the exchange.
The seller acquired 700 shares on 10/27/2025 via the exercise of stock options, with payment in cash on the same date. The filing also notes 56,350,285 shares outstanding.
FAQ
What is the current stock price of Transdigm Group (TDG)?
What is the market cap of Transdigm Group (TDG)?
